Have nanomedicines progressed as much as we’d hoped for in drug discovery and development?-Reference-Cited by-同舟云学术

Have nanomedicines progressed as much as we’d hoped for in drug discovery and development?

Published:2019-06-04 Issue:8 Volume:14 Page:723-725
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Sarmento Bruno¹²³^ORCID

Affiliation:

1. I3S – Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal

2. INEB – Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal

3. CESPU – Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde, Gandra, Portugal

Funder

European Regional Development Fund (ERDF)

FCT – Fundação para a Ciência e a Tecnologia/Ministério da Ciência, Tecnologia e Ensino Superior through the framework of project ‘Institute for Research and Innovation in Health Sciences’

Publisher

Informa UK Limited

Subject

Drug Discovery

Link

https://www.tandfonline.com/doi/pdf/10.1080/17460441.2019.1621286

Reference10 articles.

1. Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization

2. Cancer nanomedicines: So many papers and so few drugs!

3. Nanomedicines: The magic bullets reaching their target?

4. Identification of regulatory needs for nanomedicines

5. Mapping of the available standards against the regulatory needs for nanomedicines

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combining orthogonal measurements to unveil diclofenac encapsulation into polymeric and lipid nanocarriers;Analytica Chimica Acta;2023-06

2. Insights into PLGA-encapsulated epigallocatechin 3-gallate nanoparticles as a new potential biomedical system: A computational and experimental approach;European Polymer Journal;2023-01

3. Degradable multifunctional gold-liposomes as an all-in-one theranostic platform for image-guided radiotherapy;International Journal of Pharmaceutics;2022-12

4. A Nanomedicine Structure–Activity Framework for Research, Development, and Regulation of Future Cancer Therapies;ACS Nano;2022-11-02

5. The Promise of Emergent Nanobiotechnologies for In Vivo Applications and Implications for Safety and Security;Health Security;2022-10-01